Spending on World Health Organization essential medicines in Medicare Part D, 2011-15: retrospective cost analysis.

ABSTRACT:

Objectives

To characterize the trends, drivers, and potential modifiers of increased spending by US Medicare beneficiaries on medicines deemed essential by the World Health Organization.

Design

Retrospective cost analysis of Medicare Part D Prescriber Public Use File, detailing annual generic and brand name drug prescribing and spending from 2011 through 2015 by Medicare Part D participants who filled prescriptions for WHO essential medicines.

Setting

US Medicare System.

Main outcome measures

Total and per beneficiary Medicare spending, total and per beneficiary out-of-pocket patient spending, cumulative beneficiary count, claim count, and per unit drug cost. All spending measures were adjusted for inflation and reported in 2015 US dollars.

Results

Medic

SUBMITTER: Li DG 

PROVIDER: S-EPMC6635813 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature